Effects of Nicorandil and Nifedipine on Protection of Ischemic Myocardium

The effects of nicorandil and nifedipine on ischemia-reperfusion-induced myocardial infarct size following a 2-h occlusion and 30-min reperfusion period of the left anterior descending coronary artery (LAD) were compared in anesthetized dogs. Myocardial blood flow was measured using the radioactive...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of cardiovascular pharmacology 1984-05, Vol.6 (3), p.536-542
Hauptverfasser: Lamping, Kathryn A, Christensen, Carl W, Pelc, Lorie R, Warltier, David C, Gross, Garrett J
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 542
container_issue 3
container_start_page 536
container_title Journal of cardiovascular pharmacology
container_volume 6
creator Lamping, Kathryn A
Christensen, Carl W
Pelc, Lorie R
Warltier, David C
Gross, Garrett J
description The effects of nicorandil and nifedipine on ischemia-reperfusion-induced myocardial infarct size following a 2-h occlusion and 30-min reperfusion period of the left anterior descending coronary artery (LAD) were compared in anesthetized dogs. Myocardial blood flow was measured using the radioactive microsphere technique, and infarct size was determined using triphenyl tetrazolium chloride histochemical stain. Vehicle, nicorandil (100-μg/kg bolus followed by 25 μg/kg/min), or nifedipine (10-μg/kg bolus followed by 1 μg/kg/min) was administered intravenously 10 min after LAD occlusion and infused throughout the occlusion and reperfusion periods. Nicorandil and nifedipine reduced mean arterial blood pressure similarly (15 mm Hg) during infusion. However, neither drug altered collateral blood flow to the ischemic region during occlusion. In all three groups, left ventricular mass, area at risk mass, percentage of the left ventricle at risk, and retrograde flow during occlusion were similar. As compared with the control group, nicorandil reduced myocardial infarci size as determined by absolute mass, percentage of the area at risk infarcted, and percentage of the left ventricle infarcted. Nifedipine had no significant effect on infarct size. This beneficial effect of nicorandil was not related to an improvement in myocardial blood flow or a change in global hemodynamics.
doi_str_mv 10.1097/00005344-198405000-00024
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_81090555</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>81090555</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5004-1ff37f1be94226329af19ca4d6f6416aebbacec25e0464da9c6b5fd188f47913</originalsourceid><addsrcrecordid>eNp1kUtLAzEQgIMotVZ_grAH8baadzdHKT4K9XHoPWSzExrdbWqyS_HfG23tzUAew3yTDF8QKgi-IVhNb3EegnFeElVxLHJU5kn5ERoTwVjJMWXHaIyJxCXlXJ6is5TeMSZcTOUIjSTFVFVsjOb3zoHtUxFc8eJtiGbd-LbIaw4dNH7j11CEdfEWQ59Bn48ZnSe7gs7b4vkrWBMbP3Tn6MSZNsHFfp-g5cP9cvZULl4f57O7RWlzm7lh59jUkRoUp1QyqowjyhreSCc5kQbq2liwVADmkjdGWVkL15CqcnyqCJug6921mxg-B0i97nyy0LZmDWFIusp-sBAig9UOtDGkFMHpTfSdiV-aYP0jUf9J1AeJ-ldiLr3cvzHUHTSHwr21nL_a502ypnVZmvXpgClKsBQ_GN9h29D2ENNHO2wh6hWYtl_p_76QfQNGI4iP</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>81090555</pqid></control><display><type>article</type><title>Effects of Nicorandil and Nifedipine on Protection of Ischemic Myocardium</title><source>MEDLINE</source><source>Journals@Ovid LWW Legacy Archive</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Journals@Ovid Complete</source><creator>Lamping, Kathryn A ; Christensen, Carl W ; Pelc, Lorie R ; Warltier, David C ; Gross, Garrett J</creator><creatorcontrib>Lamping, Kathryn A ; Christensen, Carl W ; Pelc, Lorie R ; Warltier, David C ; Gross, Garrett J</creatorcontrib><description>The effects of nicorandil and nifedipine on ischemia-reperfusion-induced myocardial infarct size following a 2-h occlusion and 30-min reperfusion period of the left anterior descending coronary artery (LAD) were compared in anesthetized dogs. Myocardial blood flow was measured using the radioactive microsphere technique, and infarct size was determined using triphenyl tetrazolium chloride histochemical stain. Vehicle, nicorandil (100-μg/kg bolus followed by 25 μg/kg/min), or nifedipine (10-μg/kg bolus followed by 1 μg/kg/min) was administered intravenously 10 min after LAD occlusion and infused throughout the occlusion and reperfusion periods. Nicorandil and nifedipine reduced mean arterial blood pressure similarly (15 mm Hg) during infusion. However, neither drug altered collateral blood flow to the ischemic region during occlusion. In all three groups, left ventricular mass, area at risk mass, percentage of the left ventricle at risk, and retrograde flow during occlusion were similar. As compared with the control group, nicorandil reduced myocardial infarci size as determined by absolute mass, percentage of the area at risk infarcted, and percentage of the left ventricle infarcted. Nifedipine had no significant effect on infarct size. This beneficial effect of nicorandil was not related to an improvement in myocardial blood flow or a change in global hemodynamics.</description><identifier>ISSN: 0160-2446</identifier><identifier>EISSN: 1533-4023</identifier><identifier>DOI: 10.1097/00005344-198405000-00024</identifier><identifier>PMID: 6202983</identifier><identifier>CODEN: JCPCDT</identifier><language>eng</language><publisher>Philadelphia, PA: Lippincott-Raven Publishers</publisher><subject>Animals ; Antianginal agents. Coronary vasodilator agents ; Biological and medical sciences ; Cardiovascular system ; Coronary Circulation - drug effects ; Dogs ; Female ; Hemodynamics - drug effects ; Male ; Medical sciences ; Myocardial Infarction - pathology ; Myocardial Infarction - physiopathology ; Myocardial Infarction - prevention &amp; control ; Niacinamide - analogs &amp; derivatives ; Niacinamide - pharmacology ; Nicorandil ; Nifedipine - pharmacology ; Perfusion ; Pharmacology. Drug treatments ; Vasodilator Agents - pharmacology</subject><ispartof>Journal of cardiovascular pharmacology, 1984-05, Vol.6 (3), p.536-542</ispartof><rights>Lippincott-Raven Publishers.</rights><rights>1985 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5004-1ff37f1be94226329af19ca4d6f6416aebbacec25e0464da9c6b5fd188f47913</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf><![CDATA[$$Uhttp://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&PDF=y&D=ovft&AN=00005344-198405000-00024$$EPDF$$P50$$Gwolterskluwer$$H]]></linktopdf><linktohtml>$$Uhttp://ovidsp.ovid.com/ovidweb.cgi?T=JS&amp;NEWS=n&amp;CSC=Y&amp;PAGE=fulltext&amp;D=ovft&amp;AN=00005344-198405000-00024$$EHTML$$P50$$Gwolterskluwer$$H</linktohtml><link.rule.ids>314,780,784,4609,27924,27925,64666,65461</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=9210653$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/6202983$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lamping, Kathryn A</creatorcontrib><creatorcontrib>Christensen, Carl W</creatorcontrib><creatorcontrib>Pelc, Lorie R</creatorcontrib><creatorcontrib>Warltier, David C</creatorcontrib><creatorcontrib>Gross, Garrett J</creatorcontrib><title>Effects of Nicorandil and Nifedipine on Protection of Ischemic Myocardium</title><title>Journal of cardiovascular pharmacology</title><addtitle>J Cardiovasc Pharmacol</addtitle><description>The effects of nicorandil and nifedipine on ischemia-reperfusion-induced myocardial infarct size following a 2-h occlusion and 30-min reperfusion period of the left anterior descending coronary artery (LAD) were compared in anesthetized dogs. Myocardial blood flow was measured using the radioactive microsphere technique, and infarct size was determined using triphenyl tetrazolium chloride histochemical stain. Vehicle, nicorandil (100-μg/kg bolus followed by 25 μg/kg/min), or nifedipine (10-μg/kg bolus followed by 1 μg/kg/min) was administered intravenously 10 min after LAD occlusion and infused throughout the occlusion and reperfusion periods. Nicorandil and nifedipine reduced mean arterial blood pressure similarly (15 mm Hg) during infusion. However, neither drug altered collateral blood flow to the ischemic region during occlusion. In all three groups, left ventricular mass, area at risk mass, percentage of the left ventricle at risk, and retrograde flow during occlusion were similar. As compared with the control group, nicorandil reduced myocardial infarci size as determined by absolute mass, percentage of the area at risk infarcted, and percentage of the left ventricle infarcted. Nifedipine had no significant effect on infarct size. This beneficial effect of nicorandil was not related to an improvement in myocardial blood flow or a change in global hemodynamics.</description><subject>Animals</subject><subject>Antianginal agents. Coronary vasodilator agents</subject><subject>Biological and medical sciences</subject><subject>Cardiovascular system</subject><subject>Coronary Circulation - drug effects</subject><subject>Dogs</subject><subject>Female</subject><subject>Hemodynamics - drug effects</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Myocardial Infarction - pathology</subject><subject>Myocardial Infarction - physiopathology</subject><subject>Myocardial Infarction - prevention &amp; control</subject><subject>Niacinamide - analogs &amp; derivatives</subject><subject>Niacinamide - pharmacology</subject><subject>Nicorandil</subject><subject>Nifedipine - pharmacology</subject><subject>Perfusion</subject><subject>Pharmacology. Drug treatments</subject><subject>Vasodilator Agents - pharmacology</subject><issn>0160-2446</issn><issn>1533-4023</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1984</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kUtLAzEQgIMotVZ_grAH8baadzdHKT4K9XHoPWSzExrdbWqyS_HfG23tzUAew3yTDF8QKgi-IVhNb3EegnFeElVxLHJU5kn5ERoTwVjJMWXHaIyJxCXlXJ6is5TeMSZcTOUIjSTFVFVsjOb3zoHtUxFc8eJtiGbd-LbIaw4dNH7j11CEdfEWQ59Bn48ZnSe7gs7b4vkrWBMbP3Tn6MSZNsHFfp-g5cP9cvZULl4f57O7RWlzm7lh59jUkRoUp1QyqowjyhreSCc5kQbq2liwVADmkjdGWVkL15CqcnyqCJug6921mxg-B0i97nyy0LZmDWFIusp-sBAig9UOtDGkFMHpTfSdiV-aYP0jUf9J1AeJ-ldiLr3cvzHUHTSHwr21nL_a502ypnVZmvXpgClKsBQ_GN9h29D2ENNHO2wh6hWYtl_p_76QfQNGI4iP</recordid><startdate>198405</startdate><enddate>198405</enddate><creator>Lamping, Kathryn A</creator><creator>Christensen, Carl W</creator><creator>Pelc, Lorie R</creator><creator>Warltier, David C</creator><creator>Gross, Garrett J</creator><general>Lippincott-Raven Publishers</general><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>198405</creationdate><title>Effects of Nicorandil and Nifedipine on Protection of Ischemic Myocardium</title><author>Lamping, Kathryn A ; Christensen, Carl W ; Pelc, Lorie R ; Warltier, David C ; Gross, Garrett J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5004-1ff37f1be94226329af19ca4d6f6416aebbacec25e0464da9c6b5fd188f47913</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1984</creationdate><topic>Animals</topic><topic>Antianginal agents. Coronary vasodilator agents</topic><topic>Biological and medical sciences</topic><topic>Cardiovascular system</topic><topic>Coronary Circulation - drug effects</topic><topic>Dogs</topic><topic>Female</topic><topic>Hemodynamics - drug effects</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Myocardial Infarction - pathology</topic><topic>Myocardial Infarction - physiopathology</topic><topic>Myocardial Infarction - prevention &amp; control</topic><topic>Niacinamide - analogs &amp; derivatives</topic><topic>Niacinamide - pharmacology</topic><topic>Nicorandil</topic><topic>Nifedipine - pharmacology</topic><topic>Perfusion</topic><topic>Pharmacology. Drug treatments</topic><topic>Vasodilator Agents - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lamping, Kathryn A</creatorcontrib><creatorcontrib>Christensen, Carl W</creatorcontrib><creatorcontrib>Pelc, Lorie R</creatorcontrib><creatorcontrib>Warltier, David C</creatorcontrib><creatorcontrib>Gross, Garrett J</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of cardiovascular pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lamping, Kathryn A</au><au>Christensen, Carl W</au><au>Pelc, Lorie R</au><au>Warltier, David C</au><au>Gross, Garrett J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of Nicorandil and Nifedipine on Protection of Ischemic Myocardium</atitle><jtitle>Journal of cardiovascular pharmacology</jtitle><addtitle>J Cardiovasc Pharmacol</addtitle><date>1984-05</date><risdate>1984</risdate><volume>6</volume><issue>3</issue><spage>536</spage><epage>542</epage><pages>536-542</pages><issn>0160-2446</issn><eissn>1533-4023</eissn><coden>JCPCDT</coden><abstract>The effects of nicorandil and nifedipine on ischemia-reperfusion-induced myocardial infarct size following a 2-h occlusion and 30-min reperfusion period of the left anterior descending coronary artery (LAD) were compared in anesthetized dogs. Myocardial blood flow was measured using the radioactive microsphere technique, and infarct size was determined using triphenyl tetrazolium chloride histochemical stain. Vehicle, nicorandil (100-μg/kg bolus followed by 25 μg/kg/min), or nifedipine (10-μg/kg bolus followed by 1 μg/kg/min) was administered intravenously 10 min after LAD occlusion and infused throughout the occlusion and reperfusion periods. Nicorandil and nifedipine reduced mean arterial blood pressure similarly (15 mm Hg) during infusion. However, neither drug altered collateral blood flow to the ischemic region during occlusion. In all three groups, left ventricular mass, area at risk mass, percentage of the left ventricle at risk, and retrograde flow during occlusion were similar. As compared with the control group, nicorandil reduced myocardial infarci size as determined by absolute mass, percentage of the area at risk infarcted, and percentage of the left ventricle infarcted. Nifedipine had no significant effect on infarct size. This beneficial effect of nicorandil was not related to an improvement in myocardial blood flow or a change in global hemodynamics.</abstract><cop>Philadelphia, PA</cop><cop>Hagerstown, MD</cop><pub>Lippincott-Raven Publishers</pub><pmid>6202983</pmid><doi>10.1097/00005344-198405000-00024</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0160-2446
ispartof Journal of cardiovascular pharmacology, 1984-05, Vol.6 (3), p.536-542
issn 0160-2446
1533-4023
language eng
recordid cdi_proquest_miscellaneous_81090555
source MEDLINE; Journals@Ovid LWW Legacy Archive; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Journals@Ovid Complete
subjects Animals
Antianginal agents. Coronary vasodilator agents
Biological and medical sciences
Cardiovascular system
Coronary Circulation - drug effects
Dogs
Female
Hemodynamics - drug effects
Male
Medical sciences
Myocardial Infarction - pathology
Myocardial Infarction - physiopathology
Myocardial Infarction - prevention & control
Niacinamide - analogs & derivatives
Niacinamide - pharmacology
Nicorandil
Nifedipine - pharmacology
Perfusion
Pharmacology. Drug treatments
Vasodilator Agents - pharmacology
title Effects of Nicorandil and Nifedipine on Protection of Ischemic Myocardium
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T10%3A43%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20Nicorandil%20and%20Nifedipine%20on%20Protection%20of%20Ischemic%20Myocardium&rft.jtitle=Journal%20of%20cardiovascular%20pharmacology&rft.au=Lamping,%20Kathryn%20A&rft.date=1984-05&rft.volume=6&rft.issue=3&rft.spage=536&rft.epage=542&rft.pages=536-542&rft.issn=0160-2446&rft.eissn=1533-4023&rft.coden=JCPCDT&rft_id=info:doi/10.1097/00005344-198405000-00024&rft_dat=%3Cproquest_cross%3E81090555%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=81090555&rft_id=info:pmid/6202983&rfr_iscdi=true